$7.28-0.53 (-6.79%)
United States Antimony Corporation produces and sells antimony, zeolite, and precious metals in the United States and Canada.
United States Antimony Corporation in the Basic Materials sector is trading at $7.17 with a market capitalization of $1.4B. Wall Street consensus targets $13.06 (4 analysts), implying a +82.1% move over the next 12 months. The stock is currently 64% below its 52-week high of $19.71, remaining 12.4% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
United States Antimony Corporation produces and sells antimony, zeolite, and precious metals in the United States and Canada. It operates in two segments: Antimony and Zeolite. The company offers antimony trioxide that is primarily used in conjunctio...
Rare earth stocks recovered on Wednesday as analysts concluded that the Trump administration announcement of Chinese concessions amounted to very little. Both USA Rare Earth and Critical Metals rose by more than 10%. MP Materials saw more modest gains, possibly because it somewhat less focused on the heavy rare earths that are subject to Beijing's most restrictive export controls.
United States Antimony (UAMY) has drawn attention after recent share price swings, with the stock down about 19% over the past month but up roughly 13% in the past 3 months. See our latest analysis for United States Antimony. The recent pullback, including a 1 day share price return of down about 10% and a 7 day return of down about 19%, sits against a year to date share price return of about 45% and a 1 year total shareholder return above 200%. This suggests momentum has cooled in the very...
Analysts covering United States Antimony have adjusted their price targets, with one bullish research note moving from US$9 to US$11, while the modelled fair value remains at US$12.67 per share. That shift is tied closely to optimism around the planned hydrometallurgical facility at the Galena Complex, potential federal funding, and progress across the wider project pipeline. As you read on, you will see what is driving these views and how to track the evolving narrative around the...
United States Antimony (NYSE:UAMY) reported nearly flat first-quarter sales but a wider loss as management said the company is absorbing higher costs tied to an expected production ramp-up and a broader push into critical minerals beyond antimony. Senior Vice President and Chief Financial Officer R
Despite a net loss, UAMY's diversified mineral portfolio and substantial government grants position the company for future growth.